Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

  1. Hess, G.
  2. Rule, S.
  3. Jurczak, W.
  4. Jerkeman, M.
  5. Santucci Silva, R.
  6. Rusconi, C.
  7. Caballero, D.
  8. Joao, C.
  9. Witzens-Harig, M.
  10. Bence-Bruckler, I.
  11. Cho, S.-G.
  12. Zhou, W.
  13. Goldberg, J.D.
  14. Trambitas, C.
  15. Enny, C.
  16. Vermeulen, J.
  17. Traina, S.
  18. Chiou, C.-F.
  19. Diels, J.
  20. Dreyling, M.
Revue:
Leukemia and Lymphoma

ISSN: 1029-2403 1042-8194

Année de publication: 2017

Volumen: 58

Número: 12

Pages: 2824-2832

Type: Article

DOI: 10.1080/10428194.2017.1326034 GOOGLE SCHOLAR